Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Does PET with CT Have Clinical Utility in the Management of Patients with Intraductal Papillary Mucinous Neoplasm?
Design and rationale of a multi-center, pragmatic, open-label randomized trial of antimicrobial therapy - the study of clinical efficacy of antimicrobial therapy strategy using pragmatic design in Idiopathic Pulmonary Fibrosis (CleanUP-IPF) clinical trial.
The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes.
Management of HeartWare left ventricular assist device thrombosis using intracavitary thrombolytics.
The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis.
See All 17 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis.
Podolanczuk AJ, Richeldi L, Martinez FJ. The Future of Clinical Trials in Idiopathic Pulmonary Fibrosis. JAMA. 2023 05 09; 329(18):1554-1555.
View in:
PubMed
subject areas
Clinical Trials as Topic
Forecasting
Humans
Idiopathic Pulmonary Fibrosis
authors with profiles
Fernando J Martinez MD, MS